{
    "nctId": "NCT05831397",
    "briefTitle": "Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy",
    "officialTitle": "Extracellular Vesicles as a Diagnostic and Prognostic Biomarker of Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients.",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 35,
    "primaryOutcomeMeasure": "EVs levels",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signing of a specific informed consent for participation to the study\n* Female sex\n\nBC patients:\n\n* Diagnosis of breast cancer\n* Any TNM stage\n* Indication to neoadjuvant chemotherapy after multidisciplinary discussion\n\nHealthy controls:\n\n\u2022 Patients with a negative mammography, breast ultrasound or clinical breast evaluation within 12 months of the study enrolment\n\nExclusion Criteria:\n\nBC patients:\n\n\u2022 Indication to upfront surgery\n\nHealthy controls:\n\n\u2022 Diagnosis of breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}